Acute motor axonal neuropathy [76] |
ANCA, Anti-mitochondrial antibodies |
Addison’s disease [77] |
21-hydroxylase antibodies |
Anti-NMDA receptor encephalitis [78] |
Anti-GM1 |
Antiphospholipid syndrome [79] |
Antiphospholipid antibodies |
Autoimmune Encephalitis [80] |
Anti-NMDA receptor |
Autoimmune Pancreatitis [81] |
IgG4, Anti-CA2 antibodies |
Bickerstaff’s encephalitis [82] |
Various, depending on subtype (e.g., NMDA receptor antibodies, LGI1 antibodies) |
Bullous pemphigoid [83] |
Anti-BP180, Anti-BP230 |
Celiac disease [84] |
ANA, ASMA, anti-LKM1 |
Chronic inflammatory demyelinating polyneuropathy [85] |
Anti-GQ1b |
Cicatricial pemphigoid [86] |
Anti-BP180, Anti-BP230 |
Dermatitis herpetiformis [87] |
Anti-tissue transglutaminase |
Dermatomyositis [88] |
Anti-Jo1, Anti-Mi2, Anti-SRP, Anti-TIF1 |
Diabetes mellitus type 1 [89] |
Anti-insulin, anti-IA-2, anti-GAD, anti-ZnT8 antibodies |
Discoid lupus erythematosus [90] |
ANA, Anti-dsDNA, Anti-Sm |
Eosinophilic granulomatosis with polyangiitis (EGPA) [91] |
Anti-streptolysin O (ASO), anti-DNase B |
Epidermolysis bullosa acquisita [92] |
Anti-type VII collagen |
Gestational pemphigoid [93] |
Anti-BP180, Anti-BP230 |
Goodpasture syndrome [94] |
p-ANCA/MPO-ANCA |
Granulomatosis with polyangiitis (GPA) [91] |
ANCA |
Graves’ disease [95] |
TSI, TPO, TG antibodies |
Graves’ ophthalmopathy [96] |
TSH receptor antibodies |
Guillain-Barré syndrome [97] |
Various, including anti-MAG |
Hashimoto’s thyroiditis [98] |
TPO, TG antibodies |
Hemolytic anemia [99] |
Anti-red blood cell antibodies |
IgA nephropathy [100] |
Anti-GBM antibodies |
Immune thrombocytopenia [101] |
Anti-platelet antibodies |
Lambert–Eaton myasthenic syndrome [102] |
Various, including anti-GM1, anti-GD1a |
Linear IgA disease [103] |
Anti-epidermal basement membrane IgA |
Lupus nephritis [104] |
Anti-PLA2R antibodies |
Lupus vasculitis |
c-ANCA/PR3-ANCA |
Lupus vasculitis [105] |
ANA, anti-dsDNA, anti-Smith, others |
Membranous nephropathy [106] |
IgA autoantibodies |
Microscopic polyangiitis (MPA) [107] |
ANA, anti-dsDNA, anti-Smith, others |
Myasthenia gravis |
Anti-VGCC |
Myasthenia gravis [108] |
Anti-acetylcholine receptor, Anti-MuSK |
Neuromyelitis optica [109] |
Anti-AQP4, Anti-AChR, anti-MuSK; AQP4-IgG (NMO-IgG) |
Ord’s thyroiditis [110] |
TPO, TG antibodies |
Paraneoplastic cerebellar degeneration [111] |
Anti-Yo, Anti-Hu, Anti-Ri, others |
Pemphigus vulgaris [112] |
Anti-desmoglein 3, Anti-desmoglein 1 |
Pernicious anemia [113] |
Anti-tissue transglutaminase antibodies (tTG), Endomysial antibodies (EMA), Deamidated gliadin peptide (DGP) |
Polymyositis [114] |
Anti-Jo-1, Anti-SRP, others |
Premature ovarian failure [115] |
Anti-ovarian antibodies, Anti-adrenal antibodies |
Primary sclerosing cholangitis [116] |
Anti-dsDNA, Anti-Sm, Anti-nuclear antibodies |
Pulmonary alveolar proteinosis [117] |
Anti-GM-CSF antibodies |
Rheumatic heart disease [118] |
Anti-IF, Anti-parietal cell |
Rheumatoid lung disease [119] |
Rheumatoid factor, Anti-CCP antibodies |
Scleroderma (systemic sclerosis) [120] |
ANA, anti-Scl-70, anti-centromere |
Sjögren syndrome [121] |
Anti-SSA/Ro, Anti-SSB/La antibodies |
Stiff-person syndrome [122] |
Anti-GAD, anti-amphiphysin |
Sydenham’s chorea [123] |
Anti-basal ganglia |
Thrombotic thrombocytopenic purpura [124] |
ADAMTS13 autoantibodies |